187 related articles for article (PubMed ID: 34709423)
1. Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes.
Boldison J; Long AE; Aitken RJ; Wilson IV; Megson C; Hanna SJ; Wong FS; Gillespie KM
Diabetologia; 2022 Feb; 65(2):343-355. PubMed ID: 34709423
[TBL] [Abstract][Full Text] [Related]
2. Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet antigen-specific CD8
Hanna SJ; Powell WE; Long AE; Robinson EJS; Davies J; Megson C; Howell A; Jones TJ; Ladell K; Price DA; Dayan CM; Williams AJK; Gillespie KM; Wong FS
Diabetologia; 2020 Jun; 63(6):1174-1185. PubMed ID: 32157332
[TBL] [Abstract][Full Text] [Related]
3. Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.
Nocentini G; Alunno A; Petrillo MG; Bistoni O; Bartoloni E; Caterbi S; Ronchetti S; Migliorati G; Riccardi C; Gerli R
Arthritis Res Ther; 2014 Sep; 16(5):444. PubMed ID: 25256257
[TBL] [Abstract][Full Text] [Related]
4. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
5. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
6. Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA).
Radenkovic M; Silver C; Arvastsson J; Lynch K; Lernmark Å; Harris RA; Agardh CD; Cilio CM
Clin Exp Immunol; 2016 Oct; 186(1):46-56. PubMed ID: 27357431
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients.
Xufré C; Costa M; Roura-Mir C; Codina-Busqueta E; Usero L; Pizarro E; Obiols G; Jaraquemada D; Martí M
Int Immunol; 2013 Oct; 25(10):563-74. PubMed ID: 23929911
[TBL] [Abstract][Full Text] [Related]
8. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice.
Liao G; Detre C; Berger SB; Engel P; de Waal Malefyt R; Herzog RW; Bhan AK; Terhorst C
Gastroenterology; 2012 Mar; 142(3):582-591.e8. PubMed ID: 22155173
[TBL] [Abstract][Full Text] [Related]
12. Differences of Circulating CD25
Zhang J; Fu Q; He Y; Lv H; Qian Y; Zhang Y; Chen H; Xu X; Yang T; Xu K
J Immunol Res; 2022; 2022():2269237. PubMed ID: 35083339
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients.
Jin X; Zhang C; Gong L; Li H; Wang Y; Li Q; Li H
J Diabetes; 2019 Jun; 11(6):440-448. PubMed ID: 30318734
[TBL] [Abstract][Full Text] [Related]
14. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
Front Immunol; 2019; 10():19. PubMed ID: 30723474
[TBL] [Abstract][Full Text] [Related]
15. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
[TBL] [Abstract][Full Text] [Related]
16. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
17. Expansion of human regulatory T-cells from patients with type 1 diabetes.
Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
[TBL] [Abstract][Full Text] [Related]
18. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
19. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
20. Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes.
Łuczyński W; Wawrusiewicz-Kurylonek N; Stasiak-Barmuta A; Urban R; Iłendo E; Urban M; Hryszko M; Kretowski A; Górska M
Acta Biochim Pol; 2009; 56(2):361-70. PubMed ID: 19547759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
